Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Bing Mei currently holds 20,000 shares of SKYSTAR BIO-PHARMACEUTICAL CO (SKBI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Bing Mei has been a net neutral trader of SKBI stock. They have purchased $0 and sold $0 worth of shares.
Bing Mei's most recent insider trade was on Nov 9, 2018, when they sold 2,500 shares at $0.00 per share.
Bing Mei serves as Executive at SKYSTAR BIO-PHARMACEUTICAL CO (SKBI). They have executed 10 insider transactions totaling $0 over their tenure at the company.
Bing Mei holds the position of Executive at SKYSTAR BIO-PHARMACEUTICAL CO, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 14 years and currently hold a stake valued at $0.
Bing Mei has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Bing Mei was on May 4, 2012, when they purchased $46.4K worth of SKBI shares. This transaction involved 18,000 shares at $2.58 per share.
Bing Mei currently owns 20,000 shares of SKYSTAR BIO-PHARMACEUTICAL CO (SKBI), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Bing Mei's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Bing Mei has 10 Form 4 filings on record as an insider at SKYSTAR BIO-PHARMACEUTICAL CO.
Set alerts for Bing Mei and 40,000+ other insiders.